Simplex Trading
VIR icon

Simplex Trading’s Vir Biotechnology VIR Stock Holding History

Simplex Trading’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$260K Buy
29,000
+27,700
+2,131% +$221K ﹤0.01% 3985
2025
Q4 		$7.84K Sell
1,300
-1,900
-59% -$11.3K ﹤0.01% 7146
2025
Q3 		$18K Buy
3,200
+2,300
+256% +$11.8K ﹤0.01% 7433
2025
Q2 		$4K Sell
900
-6,000
-87% -$32.2K ﹤0.01% 7907
2025
Q1 		$44K Sell
6,900
-74,400
-92% -$662K ﹤0.01% 5907
2024
Q4 		$596K Buy
81,300
+76,600
+1,630% +$604K ﹤0.01% 3343
2024
Q3 		$35K Sell
4,700
-16,200
-78% -$141K ﹤0.01% 6220
2024
Q2 		$186K Buy
20,900
+8,900
+74% +$85.3K ﹤0.01% 4727
2024
Q1 		$121K Buy
12,000
+1,300
+12% +$13.2K ﹤0.01% 5398
2023
Q4 		$107K Buy
10,700
+6,300
+143% +$57.6K ﹤0.01% 5320
2023
Q3 		$41K Sell
4,400
-91,900
-95% -$1.31M ﹤0.01% 5990
2023
Q2 		$2.36M Buy
96,300
+91,800
+2,040% +$2.31M ﹤0.01% 1843
2023
Q1 		$104K Buy
4,500
+200
+5% +$5.12K ﹤0.01% 5111
2022
Q4 		$108K Sell
4,300
-23,900
-85% -$586K ﹤0.01% 4982
2022
Q3 		$543K Sell
28,200
-4,900
-15% -$125K ﹤0.01% 3378
2022
Q2 		$843K Sell
33,100
-7,300
-18% -$170K ﹤0.01% 2810
2022
Q1 		$1.04M Buy
40,400
+28,000
+226% +$830K ﹤0.01% 2875
2021
Q4 		$519K Buy
12,400
+9,992
+415% +$391K ﹤0.01% 3744
2021
Q3 		$104K Buy
2,408
+112
+5% +$4.85K ﹤0.01% 6574
2021
Q2 		$108K Buy
2,296
+2,123
+1,227% +$96.5K ﹤0.01% 6627
2021
Q1 		$252K Buy
+173
New +$9.32K ﹤0.01% 4387
2020
Q4 		– Sell
-128
Closed -$439K – 9148
2020
Q3 		$439K Buy
128
+89
+228% +$3.83K ﹤0.01% 3162
2020
Q2 		$159K Buy
39
+35
+875% +$1.18K ﹤0.01% 4269
2020
Q1 		$13K Buy
+4
New +$108 ﹤0.01% 6304

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Simplex Trading's VIR Position: Q4 2025 in Review

Simplex Trading sold out of Vir Biotechnology (VIR) in Q4 2025, closing a stake of 10,010 shares — an estimated $59.6K sold.

Simplex Trading first reported a position in VIR in Q1 2020 and held it in 16 quarters. The position peaked at $908K in Q4 2021. 218 funds tracked by Wall St. Rank hold VIR as of Q4 2025.

  • Simplex Trading reported no remaining Vir Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 10,010 Vir Biotechnology shares in Q4 2025, an estimated $59.6K.
  • Simplex Trading first reported a position in Vir Biotechnology in Q1 2020 and held it in 16 quarters.
  • Simplex Trading's Vir Biotechnology position peaked at $908K in Q4 2021.
  • 218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.